Review of outcome measurement instruments in Alzheimer's disease drug trials : Introduction : Alzheimer's disease drug trialsDEMERS, Louise; OREMUS, Mark; PERRAULT, Anne et al.Journal of geriatric psychiatry and neurology. 2000, Vol 13, Num 4, pp 161-169, issn 0891-9887Article

Review of outcome measurement instruments in Alzheimer's disease drug trials : Psychometric properties of Global scales : Alzheimer's disease drug trialsOREMUS, Mark; PERRAULT, Anne; DEMERS, Louise et al.Journal of geriatric psychiatry and neurology. 2000, Vol 13, Num 4, pp 197-205, issn 0891-9887Article

Interrater reliability of the modified Jadad Quality Scale for systematic reviews of Alzheimer's disease drug trialsOREMUS, Mark; WOLFSON, Christina; PERRAULT, Anne et al.Dementia and geriatric cognitive disorders. 2001, Vol 12, Num 3, pp 232-236, issn 1420-8008Article

Reliable individual change scores on the 3MS in older persons with dementia: Results from the Canadian Study of Health and AgingCORREA, Jose Andres; PERRAULT, Anne; WOLFSON, Christina et al.International psychogeriatrics. 2001, Vol 13, pp 71-78, issn 1041-6102, SUP1Article

Prognostic factors for functional independence in older adults with mild dementia: Results from the Canadian Study of Health and AgingPERRAULT, Anne; WOLFSON, Christina; EGAN, Mary et al.Alzheimer disease and associated disorders. 2002, Vol 16, Num 4, pp 239-247, issn 0893-0341, 9 p.Article

Review of outcome measurement instruments in Alzheimer's disease drug trials : Psychometric properties of behavior and Mood scales : Alzheimer's disease drug trialsPERRAULT, Anne; OREMUS, Mark; DEMERS, Louise et al.Journal of geriatric psychiatry and neurology. 2000, Vol 13, Num 4, pp 181-196, issn 0891-9887Article

Donepezil and rivastigmine in the treatment of Alzheimer's disease: A best-evidence synthesis of the published data on their efficacy and cost-effectivenessWOLFSON, Christina; OREMUS, Mark; SHUKLA, Vijay et al.Clinical therapeutics. 2002, Vol 24, Num 6, pp 862-886, issn 0149-2918Article